Interdisciplinary Care and Hot Topics in Movement Disorders: Jill Farmer, DO, MPH
Phase 2b Study of Parkinson Disease LRRK Inhibitor BIIB122 Initiated
AbbVie Submits sNDA for Atogepant in Chronic Migraine, Semorinemab Fails in Phase 2 Prodromal Alzheimer Study, StrivePD Software Gets FDA Greenlight
Evusheld Increased Attenuated SARS-CoV-2 Antibodies From MS B-Cell Depleting Medications